Moreira Luiz Felipe P, Galantier João, Benício Anderson, Leirner Adolfo A, Cestari Idágene A, Stolf Noedir A G
Cardiothoracic Surgery Division of the Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
Artif Organs. 2007 Apr;31(4):253-8. doi: 10.1111/j.1525-1594.2007.00372.x.
This study was performed to assess the safety and feasibility of the implantation of ventricular assist devices (VADs) as a bridge to heart transplantation in patients with advanced biventricular failure due to Chagas' disease. Six patients were submitted to paracorporeal left VAD implantation, while right ventricular dysfunction was managed clinically. The mean time of circulatory support was 27 days. Two patients were bridged to heart transplantation successfully, while the other four patients died under assistance with complications that correlated with the final situation of multiple organ failure. Nevertheless, persistent right ventricular dysfunction was observed only in one patient who survived more than 15 days, despite the general significant preoperative compromise of the right ventricle. This paradoxical observation indicates that left VAD implantation may be regarded as a valuable treatment option for patients with Chagas' disease cardiomyopathy who evolve with decompensated heart failure or cardiogenic shock.
本研究旨在评估植入心室辅助装置(VADs)作为恰加斯病所致晚期双心室衰竭患者心脏移植桥梁的安全性和可行性。6例患者接受了体外左心室辅助装置植入,而右心室功能障碍则通过临床手段进行处理。循环支持的平均时间为27天。2例患者成功过渡到心脏移植,而其他4例患者在辅助治疗期间死亡,并发症与多器官衰竭的最终情况相关。然而,尽管术前右心室普遍存在严重损害,但仅1例存活超过15天的患者出现持续性右心室功能障碍。这一矛盾的观察结果表明,对于因恰加斯病心肌病并发失代偿性心力衰竭或心源性休克的患者,植入左心室辅助装置可能是一种有价值的治疗选择。